UnitedHealth Group Incorporated (NYSE:UNH) Shares Sold by Hollencrest Capital Management

by · The Markets Daily

Hollencrest Capital Management decreased its holdings in shares of UnitedHealth Group Incorporated (NYSE:UNH – Free Report) by 0.3% in the 1st quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 136,088 shares of the healthcare conglomerate’s stock after selling 343 shares during the quarter. UnitedHealth Group makes up approximately 3.1% of Hollencrest Capital Management’s portfolio, making the stock its 7th biggest position. Hollencrest Capital Management’s holdings in UnitedHealth Group were worth $71,276,000 as of its most recent SEC filing.

Other institutional investors have also recently added to or reduced their stakes in the company. Brighton Jones LLC raised its stake in shares of UnitedHealth Group by 176.2% during the fourth quarter. Brighton Jones LLC now owns 44,249 shares of the healthcare conglomerate’s stock worth $22,384,000 after purchasing an additional 28,231 shares during the last quarter. Revolve Wealth Partners LLC raised its stake in shares of UnitedHealth Group by 137.1% during the fourth quarter. Revolve Wealth Partners LLC now owns 4,019 shares of the healthcare conglomerate’s stock worth $2,033,000 after purchasing an additional 2,324 shares during the last quarter. Bank Pictet & Cie Europe AG raised its stake in shares of UnitedHealth Group by 3.9% during the fourth quarter. Bank Pictet & Cie Europe AG now owns 263,655 shares of the healthcare conglomerate’s stock worth $133,373,000 after purchasing an additional 9,872 shares during the last quarter. Proficio Capital Partners LLC grew its holdings in UnitedHealth Group by 52.1% during the fourth quarter. Proficio Capital Partners LLC now owns 3,734 shares of the healthcare conglomerate’s stock worth $1,889,000 after acquiring an additional 1,279 shares during the period. Finally, Brooklyn FI LLC acquired a new position in UnitedHealth Group during the fourth quarter worth $1,392,000. Hedge funds and other institutional investors own 87.86% of the company’s stock.

UnitedHealth Group Stock Performance

UnitedHealth Group stock opened at $286.74 on Friday. The stock’s 50-day moving average is $306.43 and its 200-day moving average is $434.93. The company has a market cap of $260.12 billion, a price-to-earnings ratio of 12.05, a price-to-earnings-growth ratio of 1.42 and a beta of 0.45. The company has a debt-to-equity ratio of 0.71, a current ratio of 0.85 and a quick ratio of 0.85. UnitedHealth Group Incorporated has a 12 month low of $248.88 and a 12 month high of $630.73.

UnitedHealth Group (NYSE:UNH – Get Free Report) last announced its earnings results on Thursday, April 17th. The healthcare conglomerate reported $7.20 EPS for the quarter, missing the consensus estimate of $7.29 by ($0.09). The company had revenue of $109.58 billion for the quarter, compared to analysts’ expectations of $111.56 billion. UnitedHealth Group had a net margin of 5.39% and a return on equity of 26.29%. During the same quarter in the previous year, the business posted $6.91 earnings per share. Equities analysts anticipate that UnitedHealth Group Incorporated will post 29.54 earnings per share for the current year.

UnitedHealth Group Increases Dividend

The business also recently announced a quarterly dividend, which was paid on Tuesday, June 24th. Investors of record on Monday, June 16th were issued a dividend of $2.21 per share. This is an increase from UnitedHealth Group’s previous quarterly dividend of $2.10. This represents a $8.84 annualized dividend and a dividend yield of 3.08%. The ex-dividend date of this dividend was Monday, June 16th. UnitedHealth Group’s dividend payout ratio (DPR) is presently 37.02%.

Wall Street Analyst Weigh In

UNH has been the topic of a number of recent analyst reports. Truist Financial dropped their price objective on UnitedHealth Group from $360.00 to $345.00 and set a “buy” rating on the stock in a report on Wednesday. Hsbc Global Res lowered UnitedHealth Group from a “hold” rating to a “moderate sell” rating in a report on Wednesday, May 21st. Royal Bank Of Canada lowered their target price on UnitedHealth Group from $525.00 to $355.00 and set an “outperform” rating on the stock in a report on Friday, May 16th. Argus lowered UnitedHealth Group from a “buy” rating to a “hold” rating in a report on Monday, April 21st. Finally, Robert W. Baird lowered UnitedHealth Group from an “outperform” rating to a “neutral” rating and set a $312.00 target price on the stock. in a report on Wednesday, June 11th. One equities research analyst has rated the stock with a sell rating, nine have issued a hold rating and fifteen have issued a buy rating to the company’s stock. According to MarketBeat.com, UnitedHealth Group currently has a consensus rating of “Moderate Buy” and a consensus price target of $394.43.

Check Out Our Latest Analysis on UNH

Insider Activity

In other UnitedHealth Group news, Director Kristen Gil acquired 3,700 shares of the stock in a transaction on Thursday, May 15th. The stock was purchased at an average price of $271.17 per share, for a total transaction of $1,003,329.00. Following the purchase, the director directly owned 3,818 shares in the company, valued at $1,035,327.06. This trade represents a 3,135.59% increase in their ownership of the stock. The acquisition was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. Also, CEO Patrick Hugh Conway sold 589 shares of the business’s stock in a transaction that occurred on Tuesday, June 10th. The shares were sold at an average price of $305.00, for a total value of $179,645.00. Following the transaction, the chief executive officer owned 10,398 shares of the company’s stock, valued at $3,171,390. This represents a 5.36% decrease in their position. The disclosure for this sale can be found here. Insiders have acquired 109,408 shares of company stock worth $31,607,768 over the last quarter. Corporate insiders own 0.28% of the company’s stock.

About UnitedHealth Group

(Free Report)

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.

Featured Stories

Want to see what other hedge funds are holding UNH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for UnitedHealth Group Incorporated (NYSE:UNH – Free Report).